Increased FcγRIIB dominance contributes to the emergence of resistance to therapeutic antibodies in chronic lymphocytic leukaemia patients.

about

Increased FcγRIIB dominance contributes to the emergence of resistance to therapeutic antibodies in chronic lymphocytic leukaemia patients.

Item

http://www.wikidata.org/entity/Q51386372

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Increased FcγRIIB dominance co ...... ymphocytic leukaemia patients.

@en

Increased FcγRIIB dominance co ...... ymphocytic leukaemia patients.

@nl

type

Item

label

Increased FcγRIIB dominance co ...... ymphocytic leukaemia patients.

@en

Increased FcγRIIB dominance co ...... ymphocytic leukaemia patients.

@nl

prefLabel

Increased FcγRIIB dominance co ...... ymphocytic leukaemia patients.

@en

Increased FcγRIIB dominance co ...... ymphocytic leukaemia patients.

@nl

P1476

Increased FcγRIIB dominance co ...... lymphocytic leukaemia patients

@en

P2093

C Cheung

http://www.w3.org/2001/XMLSchema#string

D Gill

http://www.w3.org/2001/XMLSchema#string

L Chambers

http://www.w3.org/2001/XMLSchema#string

M Burgess

http://www.w3.org/2001/XMLSchema#string

S Mapp

http://www.w3.org/2001/XMLSchema#string

S R Mattarollo

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

New strategies in chronic lymphocytic leukemia: shifting treatment paradigms

Idelalisib and rituximab in relapsed chronic lymphocytic leukemia

Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression

Glycoengineering of therapeutic antibodies enhances monocyte/macrophage-mediated phagocytosis and cytotoxicity

Fcgamma receptors as regulators of immune responses

Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study

Impaired transendothelial migration of B-CLL lymphocytes: a defect linked to low L-selectin expression.

Current and emerging monoclonal antibody treatments for chronic lymphocytic leukemia: state of the art.

Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages.

P2888

onc.2016.387

P304

2366-2376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2016.387

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Peter Mollee

Nicholas A Saunders

Roberta Mazzieri

P577

2016-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27748757

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

lymphocyte